Stephen Scott Bylsma, MD
Ophthalmology · Santa Maria
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 37 years
- Oregon Health Sciences University School of Medicine, 1989
Offices
2 locations · Elite Eyecare Medical Group A Medical Corporation · San Luis Obispo Eye Associates, A Medical Group Inc.
Looking this up.
Hospitals listed: Marian Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bylsma’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G71086 · Current
Licensed to practise in California · since 1991 · expires 2027-04-30 · Oregon Health Sciences University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Premier Surgery Center of Santa MariaAmbulatory Surgery Center · Santa Maria, CA12% owner since 2010 · accredited by AAAHCAccreditation Renewed5 inspections, 5 with deficiencies · last 2024-11-11: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marian Regional Medical CenterSanta Maria, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.67 (0.37 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.081, Oct 2024 – Sep 2025
See every measure and the patient survey for Marian Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.67 (0.37 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.081 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0.06 to 1.93) · 1,191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 189.73 (139.29 to 240.17) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.9 · 247 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 478 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 470 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 237 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,050 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 8,823 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.42) · 8,672 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.87 (0.97 to 4.76) · 2,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.12 (0.57 to 3.67) · 782 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.85 to 3.72) · 1,934 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.63 (0 to 9.97) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (1.37 to 8.65) · 748 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.88 (0.43 to 3.32) · 373 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.73) · 6,968 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 179 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.245 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.85 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.952 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.687 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 198 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 469 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.8 · 232 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.8 · 541 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.6 · 473 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 434 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5 to 8.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (8.8 to 13.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 17) · 124 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 638 cases | No different | Jan 2024 – Dec 2024 |
What patients said (666 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$506,188
Medicare paid this office $506,188 for 1,918 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 168 | $118,010 | $445 |
| Short return visit (20+ min) | 719 | $67,741 | $66 |
| Established patient problem focused exam of visual system | 564 | $51,618 | $67 |
| Established patient complete exam of visual system | 492 | $43,453 | $87 |
| Return visit (30+ min) | 296 | $29,988 | $92 |
See all 20 services
| Removal of cataract with insertion of prosthetic lens | 168 | $118,010 | $445 |
| Short return visit (20+ min) | 719 | $67,741 | $66 |
| Established patient problem focused exam of visual system | 564 | $51,618 | $67 |
| Established patient complete exam of visual system | 492 | $43,453 | $87 |
| Return visit (30+ min) | 296 | $29,988 | $92 |
| Removal of recurring cataract in lens capsule using a laser | 69 | $23,096 | $272 |
| Imaging of optic nerve | 701 | $21,698 | $27 |
| Exam of visual field with extended testing | 369 | $20,666 | $50 |
| Removal of excessive skin and fat of upper eyelid | 22 | $14,063 | $639 |
| New patient complete exam of visual system | 138 | $13,999 | $101 |
| Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | 15 | $12,577 | $572 |
| Measurement of corneal curvature and depth of eye | 184 | $9,305 | $33 |
| New patient visit (45+ min) | 80 | $8,325 | $104 |
| Extensive repair of turning-outward eyelid defect | 17 | $7,925 | $440 |
| Photography of the retina | 103 | $3,015 | $29 |
| New patient problem focused exam of visual system | 42 | $2,506 | $60 |
| Imaging of retina | 81 | $2,485 | $31 |
| Photography of content of eyes | 96 | $2,185 | $19 |
| New patient visit (30+ min) | 30 | $1,810 | $60 |
| Ultrasound scan of cornea to determine thickness | 66 | $549 | $8 |
Procedures Medicare counted
| Cataract surgery | 322 | More than 90% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 312 | 220 | 235 | 265 | 218 | 265 |
| Removal of recurring cataract in lens capsule using a laser | 118 | 78 | 82 | 85 | 86 | 85 |
| Removal of growth of eyelid | – | 12 | 12 | 20 | – | – |
| Removal of excessive skin and fat of upper eyelid | – | – | – | – | 21 | 22 |
| Insertion of probe into nasal tear duct | 14 | – | – | – | 11 | – |
| Insertion of eye fluid drainage device | – | – | – | 12 | 12 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,918 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 16% · Women 59% · Also on Medicaid 33% · Health risk score 1.17. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 37% · Chronic kidney disease 26% · Coronary heart disease 20% · Depression 17% · Atrial fibrillation 16% · Cancer 14% · COPD 13% · Heart failure 12% · Stroke 8% · Dementia 6%.
The office billed $1,417,799, Medicare allowed $701,324 and paid $506,188; for 5,438 services of 70 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,918 | 5,438 | 76 | 1.17 | $1,417,799 | $506,188 |
| 2023 | 1,723 | 4,828 | 76 | 1.18 | $1,238,334 | $466,453 |
| 2022 | 1,781 | 5,002 | 76 | 1.15 | $1,274,923 | $493,942 |
| 2021 | 1,696 | 4,512 | 75 | 1.11 | $1,078,552 | $425,862 |
| 2020 | 1,574 | 4,121 | 75 | 1.19 | $946,307 | $367,982 |
| 2019 | 1,893 | 5,274 | 75 | 1.23 | $1,318,502 | $519,689 |
| 2018 | 1,808 | 5,358 | 75 | 1.18 | $1,334,225 | $507,471 |
| 2017 | 1,851 | 5,590 | 75 | 1.28 | $1,400,428 | $506,239 |
| 2016 | 1,883 | 5,446 | 75 | 1.21 | $1,308,428 | $484,627 |
| 2015 | 1,865 | 5,496 | 75 | 1.22 | $1,392,060 | $515,488 |
| 2014 | 1,847 | 5,721 | 75 | 1.18 | $1,519,788 | $550,305 |
| 2013 | 1,867 | 5,457 | 75 | 1.15 | $1,387,104 | $526,113 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Removal of cataract with insertion of prosthetic lens | 139 | $99,002 | $454 |
| Short return visit (20+ min) | 675 | $66,594 | $66 |
| Established patient problem focused exam of visual system | 520 | $44,237 | $70 |
| Established patient complete exam of visual system | 468 | $43,503 | $92 |
| Removal of recurring cataract in lens capsule using a laser | 65 | $24,591 | $286 |
| Return visit (30+ min) | 247 | $23,686 | $91 |
| Exam of visual field with extended testing | 405 | $22,022 | $50 |
| Imaging of optic nerve | 619 | $20,173 | $29 |
| Removal of excessive skin and fat of upper eyelid | 21 | $14,347 | $683 |
| Insertion of eye fluid drainage device | 11 | $10,421 | $868 |
| New patient complete exam of visual system | 99 | $9,944 | $100 |
| Measurement of corneal curvature and depth of eye | 149 | $7,831 | $35 |
| New patient visit (45+ min) | 48 | $5,526 | $115 |
| Photography of the retina | 128 | $3,854 | $30 |
| Imaging of retina | 111 | $3,390 | $30 |
| New patient problem focused exam of visual system | 60 | $3,164 | $53 |
| Insertion of probe into nasal tear duct | 11 | $1,703 | $155 |
| New patient visit (30+ min) | 16 | $1,464 | $91 |
| Photography of content of eyes | 27 | $500 | $19 |
| Ultrasound scan of cornea to determine thickness | 45 | $384 | $9 |
| Ct scan of cornea | 12 | $380 | $32 |
2022: 19 services
| Removal of cataract with insertion of prosthetic lens | 164 | $121,708 | $459 |
| Short return visit (20+ min) | 644 | $77,900 | $69 |
| Established patient complete exam of visual system | 508 | $44,915 | $88 |
| Established patient problem focused exam of visual system | 467 | $35,561 | $68 |
| Return visit (30+ min) | 358 | $32,631 | $88 |
| Removal of recurring cataract in lens capsule using a laser | 67 | $24,484 | $288 |
| Exam of visual field with extended testing | 401 | $22,484 | $52 |
| Imaging of optic nerve | 613 | $21,113 | $29 |
| Insertion of eye fluid drainage device | 12 | $10,433 | $869 |
| New patient complete exam of visual system | 109 | $10,144 | $93 |
| Measurement of corneal curvature and depth of eye | 176 | $9,846 | $36 |
| Removal of growth of eyelid | 20 | $5,286 | $264 |
| New patient problem focused exam of visual system | 62 | $3,977 | $64 |
| New patient visit (45+ min) | 37 | $3,868 | $105 |
| Photography of the retina | 118 | $3,452 | $29 |
| Imaging of retina | 53 | $1,937 | $34 |
| Ct scan of cornea | 25 | $716 | $29 |
| Ultrasound scan of cornea to determine thickness | 48 | $398 | $8 |
| Photography of content of eyes | 19 | $373 | $20 |
2021: 17 services
| Removal of cataract with insertion of prosthetic lens | 141 | $106,517 | $453 |
| Short return visit (20+ min) | 589 | $70,192 | $70 |
| Established patient complete exam of visual system | 528 | $48,311 | $89 |
| Established patient problem focused exam of visual system | 404 | $28,727 | $64 |
| Return visit (30+ min) | 276 | $28,298 | $96 |
| Removal of recurring cataract in lens capsule using a laser | 62 | $23,877 | $291 |
| Exam of visual field with extended testing | 393 | $20,493 | $49 |
| Imaging of optic nerve | 567 | $18,367 | $28 |
| New patient complete exam of visual system | 158 | $17,028 | $108 |
| Measurement of corneal curvature and depth of eye | 138 | $8,141 | $40 |
| Complex removal of cataract with insertion of prosthetic lens | 11 | $7,926 | $660 |
| New patient problem focused exam of visual system | 85 | $4,986 | $59 |
| New patient visit (45+ min) | 41 | $4,030 | $98 |
| Photography of the retina | 123 | $3,775 | $30 |
| Removal of growth of eyelid | 12 | $3,576 | $298 |
| Imaging of retina | 37 | $1,435 | $36 |
| Ultrasound scan of cornea to determine thickness | 66 | $584 | $9 |
2020: 14 services
| Removal of cataract with insertion of prosthetic lens | 122 | $96,965 | $441 |
| Established patient problem focused exam of visual system | 736 | $61,576 | $62 |
| Established patient complete exam of visual system | 586 | $54,138 | $90 |
| Short return visit (20+ min) | 379 | $35,591 | $60 |
| Removal of recurring cataract in lens capsule using a laser | 59 | $23,070 | $296 |
| Exam of visual field with extended testing | 342 | $18,012 | $50 |
| New patient complete exam of visual system | 155 | $14,591 | $94 |
| Imaging of optic nerve | 466 | $14,530 | $28 |
| Measurement of corneal curvature and depth of eye | 124 | $8,912 | $43 |
| Photography of the retina | 123 | $4,181 | $34 |
| New patient problem focused exam of visual system | 68 | $3,920 | $58 |
| Removal of growth of eyelid | 12 | $2,830 | $236 |
| Imaging of retina | 36 | $1,105 | $31 |
| Ultrasound scan of cornea to determine thickness | 31 | $288 | $9 |
2019: 18 services
| Removal of cataract with insertion of prosthetic lens | 192 | $163,047 | $523 |
| Established patient problem focused exam of visual system | 1,009 | $99,154 | $65 |
| Established patient complete exam of visual system | 573 | $52,968 | $91 |
| Short return visit (20+ min) | 384 | $33,066 | $56 |
| Removal of recurring cataract in lens capsule using a laser | 83 | $29,355 | $277 |
| Exam of visual field with extended testing | 423 | $22,482 | $52 |
| New patient complete exam of visual system | 222 | $22,362 | $101 |
| Imaging of optic nerve | 568 | $17,166 | $28 |
| Measurement of corneal curvature and depth of eye | 201 | $14,269 | $45 |
| Photography of the retina | 179 | $7,056 | $39 |
| New patient problem focused exam of visual system | 104 | $5,943 | $57 |
| Internal insertion of eye fluid drainage device | 18 | $4,947 | $177 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,277 | $273 |
| Insertion of probe into nasal tear duct | 12 | $2,333 | $167 |
| Return visit (30+ min) | 25 | $1,563 | $63 |
| Imaging of retina | 40 | $1,377 | $34 |
| Ultrasound scan of cornea to determine thickness | 36 | $358 | $9 |
| Photography of content of eyes | 11 | $170 | $15 |
2018: 17 services
| Removal of cataract with insertion of prosthetic lens | 202 | $176,500 | $488 |
| Established patient problem focused exam of visual system | 913 | $86,603 | $65 |
| Established patient complete exam of visual system | 563 | $50,611 | $88 |
| Short return visit (20+ min) | 495 | $39,449 | $53 |
| Exam of visual field with extended testing | 476 | $24,611 | $50 |
| Removal of recurring cataract in lens capsule using a laser | 61 | $20,031 | $274 |
| New patient complete exam of visual system | 162 | $16,583 | $102 |
| Imaging of optic nerve | 528 | $15,943 | $28 |
| Measurement of corneal curvature and depth of eye | 209 | $15,792 | $39 |
| Photography of the retina | 182 | $7,922 | $42 |
| New patient problem focused exam of visual system | 113 | $6,838 | $61 |
| Return visit (30+ min) | 69 | $5,246 | $76 |
| Insertion of probe into nasal tear duct | 11 | $1,743 | $145 |
| Imaging of retina | 25 | $783 | $31 |
| Ultrasound scan of cornea to determine thickness | 67 | $739 | $11 |
| Photography of content of eyes | 22 | $354 | $16 |
| Removal of eyelashes using forceps | 11 | $349 | $32 |
2017: 17 services
| Removal of cataract with insertion of prosthetic lens | 208 | $172,414 | $439 |
| Established patient problem focused exam of visual system | 920 | $82,786 | $60 |
| Established patient complete exam of visual system | 594 | $48,546 | $81 |
| Short return visit (20+ min) | 504 | $38,641 | $53 |
| Exam of visual field with extended testing | 514 | $25,361 | $47 |
| Measurement of corneal curvature and depth of eye | 226 | $18,077 | $36 |
| New patient complete exam of visual system | 169 | $16,682 | $99 |
| Imaging of optic nerve | 564 | $16,301 | $27 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $16,151 | $269 |
| Internal insertion of eye fluid drainage device | 13 | $11,084 | $482 |
| Photography of the retina | 189 | $9,704 | $50 |
| New patient problem focused exam of visual system | 94 | $5,289 | $56 |
| Return visit (30+ min) | 49 | $3,964 | $81 |
| Ultrasound scan of cornea to determine thickness | 73 | $850 | $11 |
| Removal of eyelashes using forceps | 13 | $605 | $43 |
| Imaging of retina | 17 | $498 | $26 |
| Photography of content of eyes | 23 | $343 | $15 |
2016: 18 services
| Removal of cataract with insertion of prosthetic lens | 174 | $147,252 | $432 |
| Short return visit (20+ min) | 810 | $72,147 | $50 |
| Established patient complete exam of visual system | 607 | $51,636 | $84 |
| Established patient problem focused exam of visual system | 595 | $40,863 | $61 |
| Exam of visual field with extended testing | 534 | $25,638 | $46 |
| Internal insertion of eye fluid drainage device | 14 | $17,123 | $815 |
| Measurement of corneal curvature and depth of eye | 197 | $16,552 | $38 |
| New patient complete exam of visual system | 169 | $16,393 | $97 |
| Imaging of optic nerve | 455 | $15,725 | $33 |
| Removal of recurring cataract in lens capsule using a laser | 43 | $13,406 | $258 |
| Photography of the retina | 206 | $12,928 | $61 |
| New patient problem focused exam of visual system | 100 | $5,196 | $52 |
| Destruction of lens tissue using laser | 12 | $4,236 | $326 |
| Imaging of retina | 28 | $961 | $34 |
| Ultrasound scan of cornea to determine thickness | 77 | $809 | $10 |
| Exam of visual field with limited testing | 25 | $621 | $25 |
| Removal of eyelashes using forceps | 14 | $592 | $35 |
| Photography of content of eyes | 25 | $331 | $13 |
2015: 17 services
| Removal of cataract with insertion of prosthetic lens | 188 | $160,091 | $408 |
| Short return visit (20+ min) | 913 | $89,374 | $52 |
| Established patient complete exam of visual system | 623 | $53,267 | $84 |
| Established patient problem focused exam of visual system | 445 | $28,582 | $60 |
| Exam of visual field with extended testing | 555 | $28,430 | $48 |
| New patient complete exam of visual system | 180 | $17,549 | $97 |
| Measurement of corneal curvature and depth of eye | 195 | $15,292 | $36 |
| Photography of the retina | 235 | $14,143 | $59 |
| Removal of recurring cataract in lens capsule using a laser | 43 | $13,776 | $270 |
| Imaging of optic nerve | 296 | $9,833 | $33 |
| New patient problem focused exam of visual system | 78 | $4,470 | $57 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $2,852 | $259 |
| Dilation of tear drainage opening | 14 | $1,751 | $103 |
| Ultrasound scan of cornea to determine thickness | 97 | $1,152 | $12 |
| Removal of eyelashes using forceps | 18 | $702 | $37 |
| Exam of visual field with limited testing | 20 | $606 | $26 |
| Photography of content of eyes | 28 | $393 | $14 |
2014: 16 services
| Removal of cataract with insertion of prosthetic lens | 224 | $195,000 | $408 |
| Short return visit (20+ min) | 864 | $87,381 | $51 |
| Established patient complete exam of visual system | 699 | $59,181 | $83 |
| Exam of visual field with extended testing | 528 | $27,855 | $49 |
| Established patient problem focused exam of visual system | 406 | $25,935 | $60 |
| Internal insertion of eye fluid drainage device | 16 | $21,797 | $807 |
| Removal of recurring cataract in lens capsule using a laser | 61 | $19,652 | $259 |
| Measurement of corneal curvature and depth of eye | 232 | $17,779 | $32 |
| Photography of the retina | 278 | $16,992 | $61 |
| New patient complete exam of visual system | 167 | $15,932 | $95 |
| Imaging of optic nerve | 345 | $11,489 | $32 |
| New patient problem focused exam of visual system | 59 | $3,327 | $56 |
| Ultrasound scan of cornea to determine thickness | 65 | $767 | $12 |
| Exam of visual field with limited testing | 25 | $656 | $26 |
| Photography of content of eyes | 33 | $504 | $15 |
| Removal of eyelashes using forceps | 12 | $467 | $39 |
2013: 18 services
| Removal of cataract with insertion of prosthetic lens | 181 | $153,337 | $441 |
| Short return visit (20+ min) | 819 | $86,330 | $53 |
| Established patient complete exam of visual system | 702 | $60,048 | $84 |
| Established patient problem focused exam of visual system | 517 | $36,710 | $62 |
| Exam of visual field with extended testing | 503 | $27,170 | $51 |
| Internal insertion of eye fluid drainage device | 15 | $17,738 | $806 |
| Creation of eye fluid drainage tract for treatment of glaucoma with previous scarring | 12 | $16,437 | $1,264 |
| Measurement of corneal curvature and depth of eye | 201 | $16,097 | $41 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $16,014 | $258 |
| New patient complete exam of visual system | 152 | $15,219 | $100 |
| Photography of the retina | 213 | $12,485 | $58 |
| Imaging of optic nerve | 348 | $11,989 | $33 |
| Removal of excessive skin and fat of upper eyelid | 12 | $8,298 | $593 |
| New patient problem focused exam of visual system | 64 | $3,553 | $56 |
| Exam of visual field with limited testing | 36 | $983 | $27 |
| Removal of eyelashes using forceps | 13 | $551 | $39 |
| Photography of content of eyes | 38 | $550 | $14 |
| Ultrasound scan of cornea to determine thickness | 44 | $501 | $11 |
Medicaid work
$89,006 in 2024
Medicaid paid $89,006 for 1,919 billed services this clinician did in 2024, up to 67 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 82 | $45,800 |
| Short return visit (20+ min) | 267 | $10,454 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 308 | $5,918 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 247 | $5,226 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 132 | $5,196 |
| DETERMINATION REFRACTIVE STATE | 428 | $3,899 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 218 | $3,745 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 60 | $2,602 |
| New patient visit (45+ min) | 14 | $1,671 |
| Return visit (30+ min) | 29 | $1,610 |
| INTRM OPH EXAM NEW PATIENT | 39 | $1,589 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 95 | $1,296 |
| 2024 | 1,919 | 12 | 67 | $89,006 |
| 2023 | 1,987 | 11 | 63 | $49,296 |
| 2022 | 1,624 | 9 | 53 | $46,808 |
| 2021 | 1,815 | 13 | 52 | $55,915 |
| 2020 | 2,387 | 13 | 62 | $64,258 |
| 2019 | 1,424 | 13 | 51 | $40,024 |
| 2018 | 278 | 7 | 25 | $5,316 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 34 | $17,079 |
| Short return visit (20+ min) | 416 | $7,300 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 293 | $5,069 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 250 | $4,823 |
| DETERMINATION REFRACTIVE STATE | 461 | $4,253 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 233 | $3,834 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 71 | $2,479 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 125 | $1,589 |
| INTRM OPH EXAM NEW PATIENT | 26 | $1,071 |
| Return visit (30+ min) | 48 | $993 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 30 | $806 |
2022
| Short return visit (20+ min) | 488 | $14,658 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 28 | $11,715 |
| Return visit (30+ min) | 124 | $7,178 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 259 | $4,146 |
| DETERMINATION REFRACTIVE STATE | 324 | $2,976 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 159 | $2,798 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 137 | $2,032 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 87 | $739 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 18 | $566 |
2021
| Short return visit (20+ min) | 415 | $13,151 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 19 | $9,516 |
| Service | 12 | $6,203 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 186 | $5,034 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 249 | $4,817 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 213 | $3,932 |
| DETERMINATION REFRACTIVE STATE | 410 | $3,731 |
| Return visit (30+ min) | 85 | $2,999 |
| INTRM OPH EXAM NEW PATIENT | 59 | $2,193 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 47 | $1,614 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 75 | $1,298 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 33 | $1,208 |
2020
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 31 | $16,141 |
| Lens, polycarbonate or equal, any index, per lens | 443 | $9,968 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 358 | $6,935 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 280 | $6,048 |
| Short return visit (20+ min) | 193 | $5,305 |
| Frames, purchases | 208 | $4,432 |
| Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 144 | $4,354 |
| DETERMINATION REFRACTIVE STATE | 359 | $3,314 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 176 | $2,965 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 43 | $1,789 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 67 | $1,257 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 69 | $1,113 |
2019
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 16 | $9,454 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 262 | $6,318 |
| Lens, polycarbonate or equal, any index, per lens | 182 | $4,095 |
| Short return visit (20+ min) | 133 | $3,842 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 74 | $3,105 |
| DETERMINATION REFRACTIVE STATE | 312 | $2,848 |
| INTRM OPH EXAM NEW PATIENT | 69 | $2,845 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 147 | $2,761 |
| Frames, purchases | 80 | $1,598 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 31 | $1,340 |
| Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 53 | $942 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 37 | $524 |
2018
| Short return visit (20+ min) | 42 | $1,187 |
| DETERMINATION REFRACTIVE STATE | 122 | $1,078 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 37 | $1,070 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $593 |
| Lens, polycarbonate or equal, any index, per lens | 24 | $540 |
| Frames, purchases | 27 | $533 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 14 | $316 |
Drugs they prescribed that Part D paid
$426,430
Pharmacies billed $426,430 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,803) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,323 generic and 1,480 brand-name prescriptions · $426,430 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 109 | $40,502 | $372 |
| Restasis | 30 | $37,694 | $1,256 |
| Rhopressa | 66 | $32,132 | $487 |
| Vyzulta | 57 | $23,883 | $419 |
| Rocklatan | 35 | $21,074 | $602 |
See all 29 drugs
| Lumigan | 109 | $40,502 | $372 |
| Restasis | 30 | $37,694 | $1,256 |
| Rhopressa | 66 | $32,132 | $487 |
| Vyzulta | 57 | $23,883 | $419 |
| Rocklatan | 35 | $21,074 | $602 |
| Simbrinza | 64 | $18,452 | $288 |
| Cyclosporine | 21 | $10,753 | $512 |
| Tobradex | 32 | $8,394 | $262 |
| Prednisolone Acetate | 262 | $7,139 | $27 |
| Latanoprost | 768 | $5,965 | $8 |
| Timolol Maleate | 105 | $5,686 | $54 |
| Alphagan P | 19 | $5,680 | $299 |
| Besivance | 21 | $4,470 | $213 |
| Neomycin-Polymyxin-Dexameth | 321 | $3,255 | $10 |
| Bromfenac | 13 | $3,146 | $242 |
| Brimonidine | 119 | $3,065 | $26 |
| Travoprost | 18 | $3,034 | $169 |
| Pilocarpine | 57 | $2,690 | $47 |
| Loteprednol Etabonate | 15 | $2,629 | $175 |
| Dorzolamide-Timolol | 139 | $2,513 | $18 |
| Ofloxacin | 194 | $1,707 | $9 |
| Difluprednate | 19 | $1,705 | $90 |
| Fluorometholone | 17 | $1,572 | $92 |
| Apraclonidine | 20 | $1,184 | $59 |
| Dorzolamide | 75 | $1,103 | $15 |
| Moxifloxacin | 33 | $827 | $25 |
| Atropine Sulfate | 11 | $394 | $36 |
| Acyclovir | 11 | $167 | $15 |
| Erythromycin | 21 | $145 | $7 |
Year by year
| 2024 | 2,803 | 796 | 0% (0) | 53% | $426,430 |
| 2023 | 2,599 | 636 | 0% (0) | 53% | $316,474 |
| 2022 | 2,404 | 597 | 0% (0) | 55% | $329,928 |
| 2021 | 2,202 | 539 | 0% (0) | 58% | $293,645 |
| 2020 | 2,260 | 495 | 0% (0) | 53% | $279,818 |
| 2019 | 2,460 | 588 | 0% (0) | 50% | $249,992 |
| 2018 | 2,796 | 634 | 0% (0) | 49% | $250,333 |
| 2017 | 2,515 | 547 | None | 49% | $220,803 |
| 2016 | 2,399 | 526 | 0% (0) | 52% | $212,062 |
| 2015 | 2,443 | 553 | None | 54% | $199,616 |
| 2014 | 2,490 | 541 | None | 55% | $184,665 |
| 2013 | 2,533 | 519 | 0% (0) | 56% | $166,650 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Restasis | 36 | $52,910 | $1,470 |
| Lumigan | 97 | $40,342 | $416 |
| Vyzulta | 87 | $33,615 | $386 |
| Rhopressa | 38 | $30,810 | $811 |
| Rocklatan | 49 | $21,046 | $430 |
| Simbrinza | 72 | $19,076 | $265 |
| Xiidra | 11 | $13,911 | $1,265 |
| Latanoprost | 788 | $10,728 | $14 |
| Alphagan P | 26 | $8,130 | $313 |
| Timolol Maleate | 119 | $7,892 | $66 |
| Prednisolone Acetate | 205 | $7,365 | $36 |
| Prolensa | 19 | $6,903 | $363 |
| Pilocarpine | 49 | $5,994 | $122 |
| Besivance | 18 | $4,190 | $233 |
| Tobradex | 14 | $3,827 | $273 |
| Travoprost | 23 | $3,764 | $164 |
| Neomycin-Polymyxin-Dexameth | 243 | $3,475 | $14 |
| Dorzolamide | 110 | $3,433 | $31 |
| Difluprednate | 20 | $3,121 | $156 |
| Dorzolamide-Timolol | 92 | $2,800 | $30 |
| Brimonidine | 145 | $2,670 | $18 |
| Ofloxacin | 135 | $1,931 | $14 |
| Moxifloxacin | 29 | $947 | $33 |
| Fluorometholone | 13 | $888 | $68 |
| Ketorolac Tromethamine | 14 | $366 | $26 |
| Erythromycin | 12 | $163 | $14 |
| Prednisone | 12 | $90 | $7 |
2022: 27 drugs
| Restasis | 41 | $63,387 | $1,546 |
| Lumigan | 108 | $43,482 | $403 |
| Vyzulta | 86 | $32,228 | $375 |
| Rhopressa | 48 | $31,371 | $654 |
| Simbrinza | 105 | $24,908 | $237 |
| Rocklatan | 39 | $14,490 | $372 |
| Xiidra | 14 | $14,351 | $1,025 |
| Latanoprost | 658 | $10,308 | $16 |
| Alphagan P | 32 | $8,965 | $280 |
| Travoprost | 43 | $8,750 | $203 |
| Prednisolone Acetate | 210 | $8,645 | $41 |
| Pilocarpine | 56 | $5,598 | $100 |
| Zioptan | 18 | $4,779 | $265 |
| Brimonidine | 128 | $4,600 | $36 |
| Combigan | 15 | $3,689 | $246 |
| Dorzolamide-Timolol | 72 | $2,987 | $41 |
| Tobradex | 12 | $2,880 | $240 |
| Neomycin-Polymyxin-Dexameth | 216 | $2,737 | $13 |
| Timolol Maleate | 79 | $2,715 | $34 |
| Dorzolamide | 82 | $2,332 | $28 |
| Difluprednate | 13 | $2,010 | $155 |
| Ofloxacin | 146 | $1,536 | $11 |
| Fluorometholone | 17 | $1,197 | $70 |
| Moxifloxacin | 24 | $726 | $30 |
| Atropine Sulfate | 13 | $477 | $37 |
| Ketorolac Tromethamine | 14 | $364 | $26 |
| Erythromycin | 12 | $75 | $6 |
2021: 27 drugs
| Restasis | 45 | $73,482 | $1,633 |
| Lumigan | 121 | $47,827 | $395 |
| Vyzulta | 80 | $25,588 | $320 |
| Simbrinza | 99 | $22,608 | $228 |
| Xiidra | 16 | $14,993 | $937 |
| Latanoprost | 677 | $13,713 | $20 |
| Rhopressa | 27 | $13,110 | $486 |
| Prednisolone Acetate | 223 | $9,221 | $41 |
| Betoptic S | 12 | $7,506 | $626 |
| Rocklatan | 13 | $6,454 | $496 |
| Alphagan P | 23 | $5,843 | $254 |
| Travoprost | 25 | $5,424 | $217 |
| Combigan | 20 | $4,693 | $235 |
| Pilocarpine | 33 | $4,128 | $125 |
| Brimonidine | 89 | $3,602 | $40 |
| Dorzolamide | 85 | $2,835 | $33 |
| Ofloxacin | 169 | $2,079 | $12 |
| Neomycin-Polymyxin-Dexameth | 154 | $1,959 | $13 |
| Timolol Maleate | 54 | $1,913 | $35 |
| Dorzolamide-Timolol | 37 | $1,691 | $46 |
| Fluorometholone | 23 | $1,523 | $66 |
| Atropine Sulfate | 12 | $596 | $50 |
| Ketorolac Tromethamine | 15 | $583 | $39 |
| Olopatadine | 18 | $568 | $32 |
| Moxifloxacin | 16 | $553 | $35 |
| Acyclovir | 21 | $243 | $12 |
| Erythromycin | 11 | $131 | $12 |
2020: 28 drugs
| Lumigan | 143 | $55,528 | $388 |
| Restasis | 32 | $49,260 | $1,539 |
| Simbrinza | 94 | $19,601 | $209 |
| Rhopressa | 30 | $13,916 | $464 |
| Alphagan P | 46 | $12,220 | $266 |
| Combigan | 51 | $12,099 | $237 |
| Vyzulta | 33 | $11,791 | $357 |
| Latanoprost | 702 | $11,262 | $16 |
| Xiidra | 12 | $9,401 | $783 |
| Travoprost | 31 | $7,627 | $246 |
| Prednisolone Acetate | 175 | $6,938 | $40 |
| Brimonidine | 89 | $5,799 | $65 |
| Rocklatan | 20 | $5,751 | $288 |
| Travatan Z | 18 | $5,235 | $291 |
| Pilocarpine | 43 | $4,297 | $100 |
| Alrex | 11 | $4,172 | $379 |
| Pazeo | 18 | $3,830 | $213 |
| Dorzolamide | 87 | $3,054 | $35 |
| Fluorometholone | 44 | $2,979 | $68 |
| Timolol Maleate | 59 | $2,604 | $44 |
| Neomycin-Polymyxin-Dexameth | 166 | $2,525 | $15 |
| Dorzolamide-Timolol | 38 | $1,803 | $47 |
| Ofloxacin | 133 | $1,698 | $13 |
| Olopatadine | 20 | $1,329 | $66 |
| Ketorolac Tromethamine | 12 | $445 | $37 |
| Moxifloxacin | 12 | $441 | $37 |
| Acyclovir | 15 | $209 | $14 |
| Erythromycin | 11 | $135 | $12 |
2019: 22 drugs
| Lumigan | 175 | $53,158 | $304 |
| Restasis | 40 | $44,669 | $1,117 |
| Travatan Z | 75 | $23,450 | $313 |
| Simbrinza | 92 | $15,683 | $170 |
| Alphagan P | 37 | $12,046 | $326 |
| Latanoprost | 719 | $10,505 | $15 |
| Prednisolone Acetate | 225 | $7,998 | $36 |
| Combigan | 37 | $7,072 | $191 |
| Timolol Maleate | 89 | $6,971 | $78 |
| Pilocarpine | 61 | $5,797 | $95 |
| Brimonidine | 112 | $5,053 | $45 |
| Rhopressa | 14 | $4,248 | $303 |
| Pazeo | 19 | $3,754 | $198 |
| Vyzulta | 11 | $3,702 | $337 |
| Tobradex | 15 | $3,449 | $230 |
| Ofloxacin | 186 | $2,947 | $16 |
| Neomycin-Polymyxin-Dexameth | 205 | $2,875 | $14 |
| Fluorometholone | 37 | $2,685 | $73 |
| Dorzolamide | 77 | $2,343 | $30 |
| Olopatadine | 20 | $1,590 | $79 |
| Dorzolamide-Timolol | 36 | $1,557 | $43 |
| Erythromycin | 18 | $203 | $11 |
2018: 22 drugs
| Lumigan | 252 | $65,407 | $260 |
| Restasis | 45 | $41,433 | $921 |
| Travatan Z | 91 | $24,883 | $273 |
| Simbrinza | 74 | $13,064 | $177 |
| Alphagan P | 51 | $10,609 | $208 |
| Prednisolone Acetate | 270 | $10,349 | $38 |
| Latanoprost | 842 | $10,038 | $12 |
| Timolol Maleate | 128 | $9,427 | $74 |
| Combigan | 42 | $9,082 | $216 |
| Restasis Multidose | 16 | $8,285 | $518 |
| Pilocarpine | 71 | $5,423 | $76 |
| Tobradex | 23 | $5,056 | $220 |
| Brimonidine | 131 | $4,156 | $32 |
| Ofloxacin | 240 | $3,601 | $15 |
| Lotemax | 11 | $3,561 | $324 |
| Neomycin-Polymyxin-Dexameth | 231 | $3,150 | $14 |
| Fluorometholone | 30 | $2,728 | $91 |
| Olopatadine | 26 | $2,453 | $94 |
| Tobramycin-Dexamethasone | 18 | $1,266 | $70 |
| Dorzolamide | 51 | $1,242 | $24 |
| Dorzolamide-Timolol | 33 | $633 | $19 |
| Acyclovir | 18 | $276 | $15 |
2017: 22 drugs
| Lumigan | 290 | $62,809 | $217 |
| Restasis | 45 | $32,287 | $717 |
| Travatan Z | 106 | $23,969 | $226 |
| Alphagan P | 75 | $14,484 | $193 |
| Latanoprost | 724 | $9,178 | $13 |
| Prednisolone Acetate | 210 | $8,859 | $42 |
| Timolol Maleate | 114 | $7,939 | $70 |
| Combigan | 34 | $6,533 | $192 |
| Simbrinza | 36 | $6,412 | $178 |
| Pataday | 34 | $6,101 | $179 |
| Pilocarpine | 64 | $3,400 | $53 |
| Neomycin-Polymyxin-Dexameth | 206 | $3,100 | $15 |
| Brimonidine | 69 | $2,867 | $42 |
| Lotemax | 11 | $2,368 | $215 |
| Ofloxacin | 149 | $2,362 | $16 |
| Dorzolamide | 90 | $2,337 | $26 |
| Durezol | 13 | $2,110 | $162 |
| Bromfenac | 11 | $1,545 | $140 |
| Dorzolamide-Timolol | 65 | $1,470 | $23 |
| Fluorometholone | 14 | $1,300 | $93 |
| Apraclonidine | 13 | $1,014 | $78 |
| Acyclovir | 27 | $348 | $13 |
2016: 23 drugs
| Lumigan | 294 | $62,287 | $212 |
| Travatan Z | 148 | $29,196 | $197 |
| Restasis | 18 | $16,787 | $933 |
| Pataday | 71 | $11,812 | $166 |
| Alphagan P | 60 | $10,212 | $170 |
| Combigan | 52 | $8,917 | $171 |
| Azopt | 29 | $7,825 | $270 |
| Latanoprost | 636 | $7,579 | $12 |
| Prednisolone Acetate | 132 | $6,010 | $46 |
| Timolol Maleate | 138 | $5,824 | $42 |
| Brimonidine | 75 | $5,355 | $71 |
| Simbrinza | 33 | $4,484 | $136 |
| Durezol | 24 | $3,685 | $154 |
| Pilocarpine | 59 | $3,384 | $57 |
| Lotemax | 14 | $3,188 | $228 |
| Neomycin-Polymyxin-Dexameth | 197 | $3,144 | $16 |
| Tobradex | 13 | $2,583 | $199 |
| Ofloxacin | 135 | $2,319 | $17 |
| Dorzolamide | 69 | $1,690 | $24 |
| Dorzolamide-Timolol | 77 | $1,395 | $18 |
| Bromfenac | 11 | $1,207 | $110 |
| Acyclovir | 12 | $170 | $14 |
| Levobunolol | 14 | $114 | $8 |
2015: 23 drugs
| Lumigan | 290 | $47,654 | $164 |
| Travatan Z | 142 | $23,606 | $166 |
| Prednisolone Acetate | 273 | $16,454 | $60 |
| Restasis | 18 | $14,195 | $789 |
| Pataday | 83 | $13,200 | $159 |
| Alphagan P | 50 | $7,501 | $150 |
| Lotemax | 40 | $7,245 | $181 |
| Azopt | 31 | $6,866 | $221 |
| Combigan | 41 | $6,554 | $160 |
| Latanoprost | 499 | $6,279 | $13 |
| Durezol | 41 | $6,154 | $150 |
| Tobradex | 26 | $5,376 | $207 |
| Brimonidine | 97 | $4,562 | $47 |
| Timolol Maleate | 90 | $3,899 | $43 |
| Pilocarpine | 45 | $3,887 | $86 |
| Patanol | 15 | $3,594 | $240 |
| Ofloxacin | 198 | $3,404 | $17 |
| Neomycin-Polymyxin-Dexameth | 161 | $2,496 | $16 |
| Simbrinza | 17 | $1,749 | $103 |
| Tobramycin-Dexamethasone | 20 | $1,724 | $86 |
| Dorzolamide | 71 | $1,649 | $23 |
| Dorzolamide-Timolol | 80 | $1,579 | $20 |
| Acyclovir | 17 | $180 | $11 |
2014: 22 drugs
| Lumigan | 279 | $41,386 | $148 |
| Travatan Z | 183 | $24,483 | $134 |
| Prednisolone Acetate | 284 | $18,191 | $64 |
| Pataday | 68 | $10,792 | $159 |
| Restasis | 29 | $10,169 | $351 |
| Alphagan P | 51 | $8,350 | $164 |
| Azopt | 47 | $7,399 | $157 |
| Latanoprost | 417 | $6,678 | $16 |
| Pilocarpine | 61 | $6,160 | $101 |
| Brimonidine | 138 | $6,137 | $44 |
| Durezol | 45 | $5,765 | $128 |
| Combigan | 33 | $4,258 | $129 |
| Betoptic S | 18 | $3,925 | $218 |
| Timolol Maleate | 87 | $3,081 | $35 |
| Lotemax | 18 | $2,993 | $166 |
| Ofloxacin | 264 | $2,835 | $11 |
| Tobradex | 16 | $2,789 | $174 |
| Neomycin-Polymyxin-Dexameth | 147 | $2,483 | $17 |
| Dorzolamide | 92 | $2,452 | $27 |
| Dorzolamide-Timolol | 70 | $2,012 | $29 |
| Simbrinza | 18 | $1,711 | $95 |
| Tobramycin-Dexamethasone | 14 | $1,246 | $89 |
2013: 24 drugs
| Lumigan | 276 | $39,007 | $141 |
| Travatan Z | 198 | $26,932 | $136 |
| Pataday | 70 | $10,007 | $143 |
| Latanoprost | 465 | $7,993 | $17 |
| Azopt | 53 | $7,613 | $144 |
| Brimonidine | 158 | $6,938 | $44 |
| Restasis | 26 | $6,918 | $266 |
| Alphagan P | 50 | $6,527 | $131 |
| Prednisolone Acetate | 270 | $6,337 | $23 |
| Tobradex | 38 | $6,305 | $166 |
| Betoptic S | 24 | $5,784 | $241 |
| Combigan | 34 | $3,840 | $113 |
| Dorzolamide | 106 | $3,369 | $32 |
| Durezol | 28 | $3,119 | $111 |
| Tobramycin-Dexamethasone | 34 | $3,076 | $90 |
| Bepreve | 11 | $2,816 | $256 |
| Pilocarpine | 38 | $2,677 | $70 |
| Timolol Maleate | 97 | $2,561 | $26 |
| Dorzolamide-Timolol | 83 | $2,372 | $29 |
| Neomycin-Polymyxin-Dexameth | 128 | $2,173 | $17 |
| Patanol | 15 | $2,073 | $138 |
| Fml Forte | 48 | $1,968 | $41 |
| Ofloxacin | 200 | $1,552 | $8 |
| Fluorometholone | 14 | $208 | $15 |
Money from drug and device companies
$1,359 in 2025
| 2025 | 7 | 22 | None | $1,359 |
| 2024 | 6 | 20 | None | $922 |
| 2023 | 5 | 21 | None | $1,044 |
| 2022 | 9 | 24 | None | $1,050 |
| 2021 | 5 | 8 | None | $434 |
| 2020 | 6 | 12 | None | $361 |
| 2019 | 6 | 14 | None | $848 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Clareon | $902 | 8 payments
|
| Abbvie | Xen Glaucoma Treatment System | $198 | 4 payments
|
| Biotissue Holdings | None | $98 | 1 payment
|
| Amgen | Tepezza | $96 | 6 payments
|
| Regeneron Healthcare Solutions | Eylea Hd | $25 | 1 payment
|
| Glaukos | Idosetr | $21 | 1 payment
|
See all 22 published payments
| Abbvie | Meals · 2025-12-16 | Durysta | $31 |
| Amgen | Meals · 2025-12-11 | Tepezza | $17 |
| Alcon Vision | Meals · 2025-11-19 | Clareon | $127 |
| Alcon Vision | Meals · 2025-11-03 | Clareon | $148 |
| Amgen | Meals · 2025-09-23 | Tepezza | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-08-21 | Eylea Hd | $25 |
| Alcon Vision | Meals · 2025-08-19 | Clareon | $16 |
| Alcon Vision | Meals · 2025-08-18 | Clareon | $80 |
| Amgen | Meals · 2025-07-22 | Tepezza | $18 |
| Alcon Vision | Meals · 2025-07-09 | Clareon | $122 |
| Amgen | Meals · 2025-06-24 | Tepezza | $17 |
| Glaukos | Meals · 2025-05-19 | Idosetr | $21 |
| Alcon Vision | Meals · 2025-05-15 | Lensx | $136 |
| Biotissue Holdings | Meals · 2025-05-08 | None | $98 |
| Abbvie | Meals · 2025-04-26 | Durysta | $35 |
| Amgen | Meals · 2025-04-17 | Tepezza | $16 |
| Abbvie | Meals · 2025-04-10 | Xen Glaucoma Treatment System | $92 |
| Alcon Vision | Meals · 2025-04-05 | Acrysof Iq Vivity | $127 |
| Amgen | Meals · 2025-04-03 | Tepezza | $14 |
| Abbvie | Meals · 2025-02-19 | Xen Glaucoma Treatment System | $40 |
| Tarsus Pharmaceuticals | Meals · 2025-02-11 | Xdemvy | $19 |
| Alcon Vision | Meals · 2025-01-16 | Lensx | $147 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $922
| Alcon Vision | Clareon | $462 | 8 payments
|
| Glaukos | Idose | $301 | 3 payments
|
| Amgen | Tepezza | $80 | 5 payments
|
| Bausch & Lomb Americas | Vyzulta | $36 | 2 payments
|
| Dompe US | Oxervate | $28 | 1 payment
|
| Abbvie | Xen Glaucoma Treatment System | $15 | 1 payment
|
2023: $1,044
| Alcon Vision | Clareon | $678 | 7 payments
|
| AbbVie | Xen Glaucoma Treatment System | $277 | 10 payments
|
| Rayner Intraocular Lenses | Omidria | $53 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $20 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $16 | 1 payment
|
2022: $1,050
| Alcon Vision | Centurion | $442 | 5 payments
|
| Abbvie | Xen Glaucoma Treatment System | $166 | 6 payments
|
| Allergan | Xen Glaucoma Treatment System | $154 | 3 payments
|
| Carl Zeiss Meditec USA | Lumera 700 | $106 | 3 payments
|
| Glaukos | Istent Inject W | $92 | 1 payment
|
| Johnson & Johnson Surgical Vision | Veritas Vision System | $30 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $24 | 1 payment
|
| Dompe US | Oxervate | $23 | 1 payment
|
| Sight Sciences | Omni(R) Surgical System (US) | $13 | 1 payment
|
2021: $434
| Sight Sciences | Omni(R) Surgical System (US) | $173 | 2 payments
|
| Aerie Pharmaceuticals | Rocklatan | $116 | 2 payments
|
| Alcon Vision | Acrysof Iq Panoptix | $79 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $34 | 2 payments
|
| Optos | Panoramic Ophthalmoscope | $31 | 1 payment
|
2020: $361
| Ivantis | Hydrus | $143 | 1 payment
|
| Alcon Vision | Acrysof Iq Panoptix | $140 | 6 payments
|
| Novartis Pharmaceuticals | Xiidra | $29 | 2 payments
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
| Sight Sciences | Omni | $16 | 1 payment
|
| Allergan | Durysta | $14 | 1 payment
|
2019: $848
| Alcon Vision | Panoptix | $509 | 6 payments
|
| Glaukos | Istent Inject Trabecular Micro-Bypass Stent System | $145 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Stellaris PC | $131 | 4 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Multifocal Family of 1-Piece Iols | $26 | 1 payment
|
| EyePoint Pharmaceuticals US | Dexycu | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Allergan, Inc. · The Efficacy and Safety of Bimatoprost Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2020 | Their institution | $16,749 |
| Allergan Inc. · Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $4,106 |
| GLAUKOS CORPORATION · 2022 | Their institution | $2,232 |
| Allergan, Inc. · Efficacy and Safety of Bimatoprost Sustained-Release (Sr) in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2020 | Their institution | $1,970 |
| Allergan Inc. · The Efficacy and Safety of Bimatoprost Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension · 2019 | Their institution | $275 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 87.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265435325
- Licence
- CA G71086California G71086: Current · expires 2027-04-30
- Trained
- Oregon Health Sciences University School of Medicine, 1989 · 37 years ago
- Group
- Elite Eyecare Medical Group A Medical Corporation · San Luis Obispo Eye Associates, A Medical Group Inc.
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G710860
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 910 E Stowell Rd, Santa Maria, CA, 93454
- NPI first listed
- 2005-05-23
- NPI last updated
- 2022-02-09
- NPI record certified
- 2022-02-09
This is when the NPI record was last certified, not a medical board exam.